Types of Cancer We Treat

Acute Myeloid Leukemia in Adults

We offer compassionate care throughout the diagnosis and treatment of acute myeloid leukemia, a rapidly growing cancer of blood-forming cells in the bone marrow, the spongy tissue in the center of bones. Our hematologist–oncologists use the latest diagnostic tools, such as molecular profiling and chromosome analysis, to create a personalized treatment plan for you. Our goal is to manage this cancer quickly with the goal of achieving remission, in which cancer cells are no longer detected in the blood.

Meet Our Doctors
Medical Oncologist Dr. Raoul Tibes
Diagnosis
Diagnosing Acute Myeloid Leukemia in Adults
Chemotherapy
Chemotherapy for Acute Myeloid Leukemia in Adults
Intrathecal Therapy
Intrathecal Therapy for Acute Myeloid Leukemia in Adults
Stem Cell Transplantation
Stem Cell Transplantation for Acute Myeloid Leukemia in Adults

Related News

High-Dose Vitamin C May Counter Leukemia
Read Story

Clinical Trials and Research Studies

Phase 1/2

AN OPEN-LABEL MULTICENTER PHASE l/1B TRIAL EVALUATING THE SAFETY ANDPHARMACOKINETICS OF ESCALATING DOSES OF BTCT4465A AS A SINGLE AGENT ANDCOMBINED WITH ATEZOLIZUMAB IN PATIENTS WITH RELAPSED OR REFRACTORYB-CELL NON-HODGKIN S LYMPHOMA AND CHRONIC LYMPHOCYTIC LEUKEMIA

Learn More

Phase 2

AALL1521: INCB 18424-269 A Phase 2 Study of the JAK1/JAK2 Inhibitor Ruxolitinib With Chemotherapy in Children With De Novo High-Risk CRLF2-Rearranged and/or JAK Pathway-Mutant Acute Lymphoblastic Leukemia (ALL)

Learn More

Phase 3

A Phase III Randomized Trial for Newly Diagnosed High Risk B-Lymphoblastic Leukemia (B-ALL) Including a Stratum Evaluating Dasatinib (NSC#732517) in Patients With Ph-like Tyrosine Kinase Inhibitor (TKI) Sensitive Mutations

Learn More

Phase 3

AALL1331; Risk-Stratified Randomized Phase III Testing of Blinatumomab (IND# 117467 NSC#765986) in First Relapse of Childhood B-Lymphoblastic Leukemia (B-ALL)

Learn More
View All Related Clinical Trials (5)